The effort started last October, when the FDA released draft guidance on classifying software as a medical device. Now, the agency is sorting through the nearly 1,400 comments it received on the guidance, Bakul Patel, the FDA’s associate center director for digital health, said May 4 at the MedCon conference in Cincinnati.
Mr. Patel said the FDA is discussing “what clinical validation looks like for software” and cited the difficulty of regulating such rapidly evolving software programs, according to Regulatory Focus.
The FDA is also creating a new digital health unit within the Center for Devices and Radiological Health to explore regulatory pathways tailored for digital health technology that relies on real world evidence, according to the report.
More articles on health IT:
Stratasan unveils software to help strengthen population health initiatives
Surgical Care Affiliates to implement HSTpathways software across 200+ facilities: 3 things to know
5 recent vendor contracts, go-lives
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
